BURBANK, Calif., Aug. 23, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, was featured in Monday's edition of The Gray Sheet, an esteemed weekly online medical devices and diagnostics publication. Emphasizing Imaging3's innovative technology, the reporter called attention to The Dominion's(tm) 3D real-time capabilities as well as its potential to produce up to 52% less radiation than conventional x-ray imaging.
The article, "Imaging3 sees future in 3D and real-time," was released in the August 21st online issue of The Gray Sheet and underscores the ease with which The Dominion is expected to produce 3D real-time images, thereby reducing the time spent in surgery. Real-time procedures can present risk and annoyance to surgical teams when today's standard fluoroscopy methods are used, due to the need to constantly realign the patient or the imaging device. Imaging3 hopes to diminish these risks through The Dominion's real-time 3D imaging.
The Chair of the American College of Radiology Commission on Pediatric Radiology, Dr. Donald Frush, was interviewed by the publication in regard to the prospective advancements The Dominion could provide to the medical world. Noting the improved speed and flexibility of the device Dr. Frush believes that a medical imaging device that produces real-time 3D images would be a technological advancement.
In addition to the focus on 3D real-time imaging, the article focused on possible ways for The Dominion to improve safety in the operating room. Imaging3's CEO, Dean Janes, was quoted on the system's potential for significantly lower radiation dose than traditional x-ray, noting that The Dominion emits short bursts of energy that "Cumulatively add up to be less than if you were to just (activate an X-ray) for a full second, so that's what allows us to have a lower form of dose." The Dominion will offer a multitude of benefits to an array of medical fields through the capacity to create instantaneous three-dimensional images, the mobility factor that allows the system to fit through a standard room door and run off a standard wall outlet, and the multi-modality capabilities including standard fluoroscopy and CT emulation.
The Gray Sheet parent company, F-D-C Reports, is one of the largest and most-respected medical and pharmaceutical news and editorial publishers in the United States, with over 15 healthcare-related publications. To view the full article, visit http://www.thegraysheet.com.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.